RxDoctor Payments Data

Kevin Gitlin, MD

Psychiatry · Plattsburgh, NYNPI 1447340229

Payments from drug & device makers

$1,387in general payments, 2019–2025

Across 62 payments — averaging $22.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Salvin Dental Specialties, Inc.$571
  • AbbVie$434
  • Lundbeck LLC$124
  • Sunovion Pharmaceuticals Inc.$82
  • Takeda Pharmaceuticals U.S.A., Inc.$54
  • Otsuka America Pharmaceutical, Inc.$36
  • plus $87 from 5 others

What the payments were for

  • Food & beverage$1,36598%
  • Education$232%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,387 in reported general payments places this provider in the 80th percentile of 3,713 psychiatry providers in New York.

See all psychiatry providers in New York

Medicare billing

Part B allowed, 2024
$69,669
Medicare patients
54
Services billed
674

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl24$34,919
TrintellixVortioxetine Hydrobromide28$34,105
RexultiBrexpiprazole15$25,307
FetzimaLevomilnacipran Hcl11$13,321
Lurasidone Hcl54$10,708
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine52$6,409
HorizantGabapentin Enacarbil12$6,050
Alprazolam ErAlprazolam35$3,501
Quetiapine Fumarate ErQuetiapine Fumarate72$2,832
Desvenlafaxine Succinate ErDesvenlafaxine Succinate65$2,746
Vilazodone Hcl18$2,524
Clonazepam141$2,043
Bupropion Hcl SrBupropion Hcl92$1,862
Alprazolam XrAlprazolam22$1,423
Duloxetine Hcl17$1,356

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar, Fetzima$434$48,24035 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$54$34,10528 claims
Otsuka America Pharmaceutical, Inc.Rexulti$36$25,30715 claims
Arbor Pharmaceuticals, Inc.Horizant$11$6,05012 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,713 psychiatry providers in New York.

Other psychiatry in Plattsburgh

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →